{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:00:12Z","timestamp":1775624412186,"version":"3.50.1"},"reference-count":106,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministry of Education, Science and Technological Development of the Republic of Serbia","doi-asserted-by":"crossref","award":["451-03-34\/2026-03\/200135"],"award-info":[{"award-number":["451-03-34\/2026-03\/200135"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AbelaPharm Probiotic Excellence Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Probiotics are widely used to support host health by modulating microbial communities and immune\u2013metabolic homeostasis. Such interventions may be particularly relevant in long COVID syndrome, a condition characterized by persistent symptoms, low-grade inflammation, and microbiota alterations following SARS-CoV-2 infection. This study investigated the effects of a multi-strain probiotic on gut microbiota composition and predicted functional potential and biochemical parameters in individuals with long COVID and convalescent participants. Healthy individuals were included as reference controls. In an interventional study, 34 participants received a 12-week probiotic formulation containing Saccharomyces boulardii, Lacticaseibacillus rhamnosus GG, and two Lactiplantibacillus plantarum strains, while 40 served as non-supplemented controls. Fecal microbiota, assessed using 16S rRNA sequencing, and biochemical markers were measured at baseline and post-intervention. Probiotic supplementation induced selective compositional changes without significantly altering overall microbial diversity. Effects were more pronounced in long COVID participants and included enrichment of bacteria associated with metabolic and immune regulation, including Adlercreutzia, Coprococcus, and Eubacterium. Functional prediction analysis identified a probiotic-responsive signature in long-COVID-affected individuals, characterized by enrichment of pathways related to energy metabolism and redox balance. These microbial changes were accompanied by a consistent trend toward reduced inflammatory and hepatic markers. Overall, probiotic intervention demonstrated microbiota-status-dependent potential in long COVID recovery.<\/jats:p>","DOI":"10.3390\/microorganisms14040734","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:05:49Z","timestamp":1775563549000},"page":"734","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-Strain Probiotic Intervention Modestly Modulates Microbial Composition and Inflammatory Profile in Individuals with Long COVID"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9615-1932","authenticated-orcid":false,"given":"Ana","family":"Ba\u010di\u0107","sequence":"first","affiliation":[{"name":"Innovation Centre of Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4694-5416","authenticated-orcid":false,"given":"Tijana","family":"Gmizi\u0107","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Clinic for Internal Medicine, University Hospital Medical Center \u201cBe\u017eanijska Kosa\u201d, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-7198","authenticated-orcid":false,"given":"Marija","family":"Brankovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Clinic for Internal Medicine, University Hospital Medical Center \u201cBe\u017eanijska Kosa\u201d, 11000 Belgrade, Serbia"},{"name":"Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1624-1557","authenticated-orcid":false,"given":"Mirjana","family":"Rajili\u0107-Stojanovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Biochemical Engineering and Biotechnology, Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cruz, C.S., Ricci, M.F., and Vieira, A.T. (2021). Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.724033"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1038\/cti.2016.38","article-title":"New Insights into Therapeutic Strategies for Gut Microbiota Modulation in Inflammatory Diseases","volume":"5","author":"Vieira","year":"2016","journal-title":"Clin. Transl. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Mutalub, Y.B., Abdulwahab, M., Mohammed, A., Yahkub, A.M., AL-Mhanna, S.B., Yusof, W., Tang, S.P., Rasool, A.H.G., and Mokhtar, S.S. (2022). Gut Microbiota Modulation as a Novel Therapeutic Strategy in Cardiometabolic Diseases. Foods, 11.","DOI":"10.3390\/foods11172575"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/lam.13333","article-title":"Gut\u2013Organ Axis: A Microbial Outreach and Networking","volume":"72","author":"Ahlawat","year":"2021","journal-title":"Lett. Appl. Microbiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00394-017-1445-8","article-title":"Gut Microbiota Functions: Metabolism of Nutrients and Other Food Components","volume":"57","author":"Rowland","year":"2018","journal-title":"Eur. J. Nutr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the Human Gut Microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_7","first-page":"26191","article-title":"Dysbiosis of the Gut Microbiota in Disease","volume":"26","author":"Carding","year":"2015","journal-title":"Microb. Ecol. Health Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hrncir, T. (2022). Gut Microbiota Dysbiosis: Triggers, Consequences, Diagnostic and Therapeutic Options. Microorganisms, 10.","DOI":"10.3390\/microorganisms10030578"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1600240","DOI":"10.1002\/mnfr.201600240","article-title":"Probiotics, Gut Microbiota, and Their Influence on Host Health and Disease","volume":"61","author":"Delgado","year":"2017","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12088-019-00808-y","article-title":"Recent Advancements in the Development of Modern Probiotics for Restoring Human Gut Microbiome Dysbiosis","volume":"60","author":"Kumar","year":"2020","journal-title":"Indian J. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/MCG.0000000000002002","article-title":"World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics","volume":"58","author":"Guarner","year":"2024","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9478630","DOI":"10.1155\/2018\/9478630","article-title":"Probiotic Species in the Modulation of Gut Microbiota: An Overview","volume":"2018","author":"Azad","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Chandrasekaran, P., Weiskirchen, S., and Weiskirchen, R. (2024). Effects of Probiotics on Gut Microbiota: An Overview. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116022"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1080\/10408398.2011.619671","article-title":"Immune System Stimulation by Probiotic Microorganisms","volume":"54","author":"Ashraf","year":"2014","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Yoo, J.Y., and Kim, S.S. (2016). Probiotics and Prebiotics: Present Status and Future Perspectives on Metabolic Disorders. Nutrients, 8.","DOI":"10.3390\/nu8030173"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 Pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41575-022-00698-4","article-title":"Gut Microbiota in COVID-19: Key Microbial Changes, Potential Mechanisms and Clinical Applications","volume":"20","author":"Zhang","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"110195","DOI":"10.1016\/j.biopha.2020.110195","article-title":"New Understanding of the Damage of SARS-CoV-2 Infection Outside the Respiratory System","volume":"127","author":"Zhang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e00133-20","DOI":"10.1128\/CMR.00133-20","article-title":"Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systemic Infection","volume":"34","author":"Synowiec","year":"2021","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","article-title":"Innate Immune and Inflammatory Responses to SARS-CoV-2: Implications for COVID-19","volume":"29","author":"Lowery","year":"2021","journal-title":"Cell Host Microbe"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Durairajan, S.S.K., Singh, A.K., Saravanan, U.B., Namachivayam, M., Radhakrishnan, M., Huang, J.-D., Dhodapkar, R., and Zhang, H. (2023). Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications. Viruses, 15.","DOI":"10.3390\/v15061231"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"198018","DOI":"10.1016\/j.virusres.2020.198018","article-title":"Gut Microbiota and COVID-19-Possible Link and Implications","volume":"285","author":"Dhar","year":"2020","journal-title":"Virus Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Smail, S.W., Albarzinji, N., Salih, R.H., Taha, K.O., Hirmiz, S.M., Ismael, H.M., Noori, M.F., Azeez, S.S., and Janson, C. (2025). Microbiome Dysbiosis in SARS-CoV-2 Infection: Implication for Pathophysiology and Management Strategies of COVID-19. Front. Cell. Infect. Microbiol., 15.","DOI":"10.3389\/fcimb.2025.1537456"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"w30091","DOI":"10.4414\/SMW.2021.w30091","article-title":"Long COVID 1 Year after Hospitalisation for COVID-19: A Prospective Bicentric Cohort Study","volume":"151","author":"Becker","year":"2021","journal-title":"Swiss Med. Wkly."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinf.2023.12.004","article-title":"Persistence of Post-COVID Symptoms in the General Population Two Years after SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis","volume":"88","author":"Notarte","year":"2024","journal-title":"J. Infect."},{"key":"ref_27","first-page":"112","article-title":"Global Prevalence of Post-COVID-19 Condition: A Systematic Review and Meta-Analysis of Prospective Evidence","volume":"45","author":"Taher","year":"2025","journal-title":"Health Promot. Chronic Dis. Prev. Can. Res. Policy Pract."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Proal, A.D., and VanElzakker, M.B. (2021). Long COVID or Post-Acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Contribute to Persistent Symptoms. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.698169"},{"key":"ref_29","unstructured":"Goldowitz, I., Worku, T., Brown, L., and Fineberg, H.V. (2024). A Long COVID Definition: A Chronic, Systemic Disease State with Profound Consequences, National Academies Press (US)."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sk Abd Razak, R., Ismail, A., Abdul Aziz, A.F., Suddin, L.S., Azzeri, A., and Sha\u2019ari, N.I. (2024). Post-COVID Syndrome Prevalence: A Systematic Review and Meta-Analysis. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-19264-5"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0140-6736(24)01136-X","article-title":"Long COVID: A Clinical Update","volume":"404","author":"Greenhalgh","year":"2024","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing Long COVID in an International Cohort: 7 Months of Symptoms and Their Impact","volume":"38","author":"Davis","year":"2021","journal-title":"eClinicalMedicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: Major Findings, Mechanisms and Recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2457495","DOI":"10.1080\/19490976.2025.2457495","article-title":"Long COVID and Gut Microbiome: Insights into Pathogenesis and Therapeutics","volume":"17","author":"Lau","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-022-00986-0","article-title":"Alterations in Microbiota of Patients with COVID-19: Potential Mechanisms and Therapeutic Interventions","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41590-025-02353-x","article-title":"Long COVID Involves Activation of Proinflammatory and Immune Exhaustion Pathways","volume":"27","author":"Aid","year":"2025","journal-title":"Nat. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10020-024-00986-6","article-title":"Chronic Inflammation in Post-Acute Sequelae of COVID-19 Modulates Gut Microbiome: A Review of Literature on COVID-19 Sequelae and Gut Dysbiosis","volume":"31","author":"Iqbal","year":"2025","journal-title":"Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"An, Y., He, L., Xu, X., Piao, M., Wang, B., Liu, T., and Cao, H. (2024). Gut Microbiota in Post-Acute COVID-19 Syndrome: Not the End of the Story. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1500890"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/gutjnl-2021-324090","article-title":"Six-Month Follow-up of Gut Microbiota Richness in Patients with COVID-19","volume":"71","author":"Chen","year":"2022","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Tkacheva, O.N., Klimenko, N.S., Kashtanova, D.A., Tyakht, A.V., Maytesyan, L.V., Akopyan, A.A., Koshechkin, S.I., and Strazhesko, I.D. (2023). Gut Microbiome in Post-COVID-19 Patients Is Linked to Immune and Cardiovascular Health Status but Not COVID-19 Severity. Microorganisms, 11.","DOI":"10.3390\/microorganisms11041036"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1159\/000548507","article-title":"Gut Microbiota as a Key Player in Health and Disease with a Focus on Long-Term Alterations in Post-COVID","volume":"43","year":"2025","journal-title":"Dig. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.3346\/jkms.2023.38.e120","article-title":"Gut Microbiota Dysbiosis Correlates with Long COVID-19 at One-Year After Discharge","volume":"38","author":"Zhang","year":"2023","journal-title":"J. Korean Med. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1136\/gutjnl-2022-328319","article-title":"Post-Acute COVID-19 Syndrome and Gut Dysbiosis Linger beyond 1 Year after SARS-CoV-2 Clearance","volume":"72","author":"Su","year":"2023","journal-title":"Gut"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e28289","DOI":"10.1002\/jmv.28289","article-title":"Clinical Trials on the Pharmacological Treatment of Long COVID: A Systematic Review","volume":"95","author":"Chee","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Bonilla, H., Peluso, M.J., Rodgers, K., Aberg, J.A., Patterson, T.F., Tamburro, R., Baizer, L., Goldman, J.D., Rouphael, N., and Deitchman, A. (2023). Therapeutic Trials for Long COVID-19: A Call to Action from the Interventions Taskforce of the RECOVER Initiative. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1129459"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Jach, M.E., Sajnaga, E., Bumbul, M., Serefko, A., Borowicz, K.K., Golczyk, H., Kieliszek, M., and Wiater, A. (2025). The Role of Probiotics and Their Postbiotic Metabolites in Post-COVID-19 Syndrome. Molecules, 30.","DOI":"10.3390\/molecules30204130"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"\u0141oniewski, I., Skonieczna-\u017bydecka, K., So\u0142ek-Pastuszka, J., and Marlicz, W. (2022). Probiotics in the Management of Mental and Gastrointestinal Post-COVID Symptomes. J. Clin. Med., 11.","DOI":"10.3390\/jcm11175155"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"17534259251362023","DOI":"10.1177\/17534259251362023","article-title":"Immunity\u2019s Core Reset: Synbiotics and Gut Microbiota in the COVID-19 Era","volume":"31","year":"2025","journal-title":"Innate Immun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"110947","DOI":"10.1016\/j.biopha.2020.110947","article-title":"SARS-CoV-2 Microbiome Dysbiosis Linked Disorders and Possible Probiotics Role","volume":"133","author":"Din","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Taufer, C.R., da Silva, J., and Rampelotto, P.H. (2024). The Influence of Probiotic Lactobacilli on COVID-19 and the Microbiota. Nutrients, 16.","DOI":"10.3390\/nu16091350"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s12602-022-09953-1","article-title":"Unique Probiotic Properties and Bioactive Metabolites of Saccharomyces Boulardii","volume":"15","author":"Fu","year":"2023","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1039\/D1FO02752B","article-title":"Saccharomyces Boulardii Alleviates DSS-Induced Intestinal Barrier Dysfunction and Inflammation in Humanized Mice","volume":"13","author":"Li","year":"2022","journal-title":"Food Funct."},{"key":"ref_53","unstructured":"(2025, August 18). Terapijski Protokol COVID-19 06.07.verzija8.pdf [Internet]. Available online: https:\/\/www.lks.org.rs\/images\/Documents\/Obavestenja\/Terapijski%20protokol%20COVID-19%20%2006.07.verzija8%20(1).pdf."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2298\/HEMIND220502011K","article-title":"Improving the Stability of a Probiotic Product with Lactiplantibacillus Plantarum 299v by Introducing Flow Pack Bags: Technical Paper","volume":"77","author":"Katona","year":"2023","journal-title":"Hem. Ind. Chem. Ind."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e00095-16","DOI":"10.1128\/mSystems.00095-16","article-title":"Impact of Sample Type and DNA Isolation Procedure on Genomic Inference of Microbiome Composition","volume":"1","author":"Knudsen","year":"2016","journal-title":"mSystems"},{"key":"ref_56","unstructured":"Andrews, S. (2025, November 20). FastQC: A Quality Control Tool for High Throughput Sequence Data. Available online: https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, Interactive, Scalable and Extensible Microbiome Data Science Using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nmeth.3869","article-title":"DADA2: High-Resolution Sample Inference from Illumina Amplicon Data","volume":"13","author":"Callahan","year":"2016","journal-title":"Nat. Methods"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Price, M.N., Dehal, P.S., and Arkin, A.P. (2010). FastTree 2\u2013Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0009490"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA Ribosomal RNA Gene Database Project: Improved Data Processing and Web-Based Tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_61","unstructured":"Bisanz, J.E. (2025, November 20). qiime2R: Importing QIIME2 Artifacts and Associated Data into R Sessions. Available online: https:\/\/github.com\/jbisanz\/qiime2R."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"McMurdie, P.J., and Holmes, S. (2013). Phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061217"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting Linear Mixed-Effects Models Using Lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wickham, H. (2016). Ggplot2: Elegant Graphics for Data Analysis; Use R!, Springer International Publishing.","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"ref_65","unstructured":"Lahti, L., and Shetty, S. (Microbiome R Package, 2017). Microbiome R Package, Release (3.22)."},{"key":"ref_66","unstructured":"Yang, C., Zhang, X., and Chen, J. (MicrobiomeStat: Comprehensive Statistical and Visualization Methods for Microbiome and Multi-Omics Data, 2025). MicrobiomeStat: Comprehensive Statistical and Visualization Methods for Microbiome and Multi-Omics Data, R package version 1."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"McMurdie, P.J., and Holmes, S. (2014). Waste Not, Want Not: Why Rarefying Microbiome Data Is Inadmissible. PLoS Comput. Biol., 10.","DOI":"10.1371\/journal.pcbi.1003531"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1038\/s41598-021-87865-w","article-title":"Anxiolytic Effects of a Galacto-Oligosaccharides Prebiotic in Healthy Females (18\u201325 Years) with Corresponding Changes in Gut Bacterial Composition","volume":"11","author":"Johnstone","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/wps.20672","article-title":"The Efficacy and Safety of Nutrient Supplements in the Treatment of Mental Disorders: A Meta-Review of Meta-Analyses of Randomized Controlled Trials","volume":"18","author":"Firth","year":"2019","journal-title":"World Psychiatry"},{"key":"ref_70","unstructured":"Anderson, M.J. (2017). Permutational Multivariate Analysis of Variance (PERMANOVA). Wiley StatsRef: Statistics Reference Online, John Wiley & Sons, Ltd."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13059-022-02655-5","article-title":"LinDA: Linear Models for Differential Abundance Analysis of Microbiome Compositional Data","volume":"23","author":"Zhou","year":"2022","journal-title":"Genome Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","article-title":"PICRUSt2 for Prediction of Metagenome Functions","volume":"38","author":"Douglas","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a Reference Resource for Gene and Protein Annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"D445","DOI":"10.1093\/nar\/gkz862","article-title":"The MetaCyc Database of Metabolic Pathways and Enzymes\u2014A 2019 Update","volume":"48","author":"Caspi","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13099-023-00546-z","article-title":"Association of Gut Microbial Dysbiosis with Disease Severity, Response to Therapy and Disease Outcomes in Indian Patients with COVID-19","volume":"15","author":"Talukdar","year":"2023","journal-title":"Gut Pathog."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.1007\/s12035-025-04769-w","article-title":"Alterations in Gut Microbiome Composition and Increased Inflammatory Markers in Post-COVID-19 Individuals","volume":"62","author":"Barichello","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Wie\u00ebrs, G., Belkhir, L., Enaud, R., Leclercq, S., Philippart de Foy, J.-M., Dequenne, I., de Timary, P., and Cani, P.D. (2020). How Probiotics Affect the Microbiota. Front. Cell. Infect. Microbiol., 9.","DOI":"10.3389\/fcimb.2019.00454"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"\u00c9li\u00e1s, A.J., F\u00f6ldv\u00e1ri-Nagy, K.C., Al-Gharati, Y.Z., Veres, D.S., Schnabel, T., Teutsch, B., Er\u0151ss, B., Hegyi, P., Lenti, K., and F\u00f6ldv\u00e1ri-Nagy, L. (2026). Effect of Probiotic Supplementation on the Gut Microbiota Diversity in Healthy Populations: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. BMC Med., 24.","DOI":"10.1186\/s12916-025-04602-0"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Santacruz, C., Tyrkalska, S.D., and Candel, S. (2024). The Microbiota in Long COVID. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021330"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut Microbiota Dynamics in a Prospective Cohort of Patients with Post-Acute COVID-19 Syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Mussabay, K., Kozhakhmetov, S., Dusmagambetov, M., Mynzhanova, A., Nurgaziyev, M., Jarmukhanov, Z., Vinogradova, E., Dusmagambetova, A., Daulbaeva, A., and Chulenbayeva, L. (2024). Gut Microbiome and Cytokine Profiles in Post-COVID Syndrome. Viruses, 16.","DOI":"10.3390\/v16050722"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Li, S., Yang, S., Zhou, Y., Disoma, C., Dong, Z., Du, A., Zhang, Y., Chen, Y., Huang, W., and Chen, J. (2021). Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients with Altered Gut Microbiota. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.712081"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s43556-022-00103-1","article-title":"Alterations of the Fecal Microbiota in Relation to Acute COVID-19 Infection and Recovery","volume":"3","author":"Yin","year":"2022","journal-title":"Mol. Biomed."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"O\u00f1ate, F.P., Chamignon, C., Burz, S.D., Lapaque, N., Monnoye, M., Philippe, C., Bredel, M., Ch\u00eane, L., Farin, W., and Paillarse, J.-M. (2023). Adlercreutzia Equolifaciens Is an Anti-Inflammatory Commensal Bacterium with Decreased Abundance in Gut Microbiota of Patients with Metabolic Liver Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512232"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.chom.2024.04.005","article-title":"The Gut Microbiome Associates with Phenotypic Manifestations of Post-Acute COVID-19 Syndrome","volume":"32","author":"Su","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Nogal, A., Louca, P., Zhang, X., Wells, P.M., Steves, C.J., Spector, T.D., Falchi, M., Valdes, A.M., and Menni, C. (2021). Circulating Levels of the Short-Chain Fatty Acid Acetate Mediate the Effect of the Gut Microbiome on Visceral Fat. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.711359"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1802866","DOI":"10.1080\/19490976.2020.1802866","article-title":"Gut Microbes from the Phylogenetically Diverse Genus Eubacterium and Their Various Contributions to Gut Health","volume":"12","author":"Mukherjee","year":"2020","journal-title":"Gut Microbes"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"004987","DOI":"10.1099\/ijsem.0.004987","article-title":"Adlercreutzia rubneri sp. nov., a Resveratrol-Metabolizing Bacterium Isolated from Human Faeces and Emended Description of the Genus Adlercreutzia","volume":"71","author":"Stoll","year":"2021","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2520407","DOI":"10.1080\/19490976.2025.2520407","article-title":"Probiotic-Induced Enrichment of Adlercreutzia Equolifaciens Increases Gut Microbiome Wellness Index and Maps to Lower Host Blood Glucose Levels","volume":"17","author":"Zhang","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1099\/ijs.0.016774-0","article-title":"Slackia Equolifaciens Sp. Nov., a Human Intestinal Bacterium Capable of Producing Equol","volume":"60","author":"Jin","year":"2010","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/gmic.1.3.12013","article-title":"Responders and Non-Responders to Probiotic Interventions: How Can We Improve the Odds?","volume":"1","author":"Reid","year":"2010","journal-title":"Gut Microbes"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2178794","DOI":"10.1080\/19490976.2023.2178794","article-title":"Randomized Controlled Trial Demonstrates Response to a Probiotic Intervention for Metabolic Syndrome That May Correspond to Diet","volume":"15","author":"Wastyk","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12760","article-title":"The Immune Response to Prevotella Bacteria in Chronic Inflammatory Disease","volume":"151","author":"Larsen","year":"2017","journal-title":"Immunology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"25180","DOI":"10.1021\/jacs.5c08613","article-title":"Eggerthella Lenta Produces a Cryptic Pro-Inflammatory Lipid","volume":"147","author":"Shin","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"e00524","DOI":"10.14309\/ctg.0000000000000524","article-title":"Decreased Gut Microbiome Tryptophan Metabolism and Serotonergic Signaling in Patients with Persistent Mental Health and Gastrointestinal Symptoms After COVID-19","volume":"13","author":"Blackett","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Tobi, M., Chaudhari, D., Ryan, E.P., Rossi, N.F., Koka, O., Baxter, B., Tipton, M., Dutt, T.S., Tobi, Y., and McVicker, B. (2025). Immune Signatures in Post-Acute Sequelae of COVID-19 (PASC) and Myalgia\/Chronic Fatigue Syndrome (ME\/CFS): Insights from the Fecal Microbiome and Serum Cytokine Profiles. Biomolecules, 15.","DOI":"10.3390\/biom15070928"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"22496","DOI":"10.1038\/s41598-023-49601-4","article-title":"The Biomarkers\u2019 Landscape of Post-COVID-19 Patients Can Suggest Selective Clinical Interventions","volume":"13","author":"Paris","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s40121-025-01167-6","article-title":"Gut Microbial Signatures in Long COVID: Potential Biomarkers and Therapeutic Targets","volume":"14","author":"Oh","year":"2025","journal-title":"Infect. Dis. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Horvath, A., Haller, R., Feldbacher, N., Habisch, H., \u017dukauskait\u0117, K., Madl, T., and Stadlbauer, V. (2024). Probiotic Therapy of Gastrointestinal Symptoms During COVID-19 Infection: A Randomized, Double-Blind, Placebo-Controlled, Remote Study. Nutrients, 16.","DOI":"10.3390\/nu16223970"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Horvath, A., Habisch, H., Prietl, B., Pfeifer, V., Balazs, I., Kovacs, G., Foris, V., John, N., Kleinschek, D., and Feldbacher, N. (2024). Alteration of the Gut\u2013Lung Axis After Severe COVID-19 Infection and Modulation Through Probiotics: A Randomized, Controlled Pilot Study. Nutrients, 16.","DOI":"10.3390\/nu16223840"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Laterza, L., Putignani, L., Settanni, C.R., Petito, V., Varca, S., De Maio, F., Macari, G., Guarrasi, V., Gremese, E., and Tolusso, B. (2023). Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076623"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Rossi, F., Amadoro, C., Pallotta, M.L., and Colavita, G. (2022). Variability of Genetic Characters Associated with Probiotic Functions in Lacticaseibacillus Species. Microorganisms, 10.","DOI":"10.20944\/preprints202204.0029.v1"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"107963","DOI":"10.1016\/j.micpath.2025.107963","article-title":"Exploring Regional Variations in Probiotics: Implications for Efficacy and Application","volume":"208","author":"Abavisani","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2018899","DOI":"10.1080\/19490976.2021.2018899","article-title":"Probiotic Improves Symptomatic and Viral Clearance in Covid19 Outpatients: A Randomized, Quadruple-Blinded, Placebo-Controlled Trial","volume":"14","year":"2022","journal-title":"Gut Microbes"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00203-025-04496-9","article-title":"Pediococcus Pentosaceus Strain SPARC2 as a Potential Probiotic Food Supplement: Genomic Insight, Probiotic Potential, and Biosafety Profiling in BALB\/c Mice","volume":"207","author":"Butt","year":"2025","journal-title":"Arch. Microbiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e01202-20","DOI":"10.1128\/mSphere.01202-20","article-title":"Primer, Pipelines, Parameters: Issues in 16S rRNA Gene Sequencing","volume":"6","author":"Matchado","year":"2021","journal-title":"mSphere"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/734\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:20:20Z","timestamp":1775622020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/14\/4\/734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":106,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["microorganisms14040734"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms14040734","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}